{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T22:34:47Z","timestamp":1772318087502,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Melissa Fallers"},{"name":"Jane J. Clarke"},{"name":"Ljubica Krsmanovic"},{"name":"Valentine O. Wagner III"},{"name":"Chuck Powley"},{"name":"DuPont Company"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.yrtph.2010.09.007","type":"journal-article","created":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T04:49:04Z","timestamp":1285217344000},"page":"53-63","source":"Crossref","is-referenced-by-count":14,"title":["Safety assessment of EPA-rich triglyceride oil produced from yeast: Genotoxicity and 28-day oral toxicity in rats"],"prefix":"10.1016","volume":"59","author":[{"given":"Leigh A.","family":"Belcher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan A.","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Donner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg P.","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Frame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2010.09.007_b0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1939-165X.1996.tb00968.x","article-title":"Comparative lipid and lipoprotein metabolism","volume":"25","author":"Bauer","year":"1996","journal-title":"Vet. Clin. Pathol."},{"key":"10.1016\/j.yrtph.2010.09.007_b0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0278-6915(96)00019-1","article-title":"Preclinical evaluation of single-cell oils that are highly enriched with arachidonic acid and docosahexaenoic acid","volume":"34","author":"Boswell","year":"1996","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2010.09.007_b0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.atherosclerosis.2006.06.008","article-title":"Age- and dose-dependent effects of an eicosapentaenoic acid-rich oil on cardiovascular risk factors in healthy male subjects","volume":"193","author":"Cazzola","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.yrtph.2010.09.007_b0020","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.psychres.2007.06.029","article-title":"Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients: results from a randomized placebo-controlled trial","volume":"161","author":"Emsley","year":"2008","journal-title":"Psych. Res."},{"issue":"suppl","key":"10.1016\/j.yrtph.2010.09.007_b0025","doi-asserted-by":"crossref","first-page":"1526S","DOI":"10.1093\/ajcn\/83.6.1526S","article-title":"N-3 Fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits","volume":"83","author":"Gebauer","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.yrtph.2010.09.007_b0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ajcn\/66.3.649","article-title":"Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids","volume":"66","author":"Grimsgaard","year":"1997","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.yrtph.2010.09.007_b0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.yrtph.2008.08.015","article-title":"Safety assessment of SDA soybean oil: results of a 28-day gavage study and a 90-day\/one generation reproduction feeding study in rats","volume":"52","author":"Hammond","year":"2008","journal-title":"Reg. Toxicol. Pharmacol"},{"key":"10.1016\/j.yrtph.2010.09.007_b0040","doi-asserted-by":"crossref","first-page":"804S","DOI":"10.3945\/jn.108.101329","article-title":"Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids","volume":"139","author":"Harris","year":"2009","journal-title":"J. Nutr."},{"key":"10.1016\/j.yrtph.2010.09.007_b0045","unstructured":"Institute for Laboratory Animal Research, 1996. Guide for the Care and Use of Laboratory Animals (National Academies Press, Washington, D.C.)."},{"key":"10.1016\/j.yrtph.2010.09.007_b0050","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000038493.65177.94","article-title":"Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease","volume":"106","author":"Kris-Etherton","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.yrtph.2010.09.007_b0055","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jada.2008.04.025","article-title":"N-3 fatty acids: food or supplements?","volume":"108","author":"Kris-Etherton","year":"2008","journal-title":"J. Am. Dietetic Assoc."},{"key":"10.1016\/j.yrtph.2010.09.007_b0060","doi-asserted-by":"crossref","unstructured":"MacKenzie, S. A., Belcher, L. A., Sykes, G. P., Frame, S.R., Mukerji, P., Gillies, P. J., (2010). Safety assessment of an EPA-rich oil produced from yeast: results of a 90-day subchronic toxicity study. Reg. Toxicol. Pharmacol, in press.","DOI":"10.1016\/j.yrtph.2010.08.021"},{"key":"10.1016\/j.yrtph.2010.09.007_b0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3177\/jnsv.47.201","article-title":"Subchronic toxicity of fish oil concentrates in male and female rats","volume":"47","author":"Rabbani","year":"2001","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"10.1016\/j.yrtph.2010.09.007_b0070","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/ajcn\/54.3.438","article-title":"Omega-3 fatty acids in health and disease and in growth and development","volume":"54","author":"Simopoulos","year":"1991","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.yrtph.2010.09.007_b0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lfs.2008.04.011","article-title":"Eicosapentaenoic acid lowers plasma and liver cholesterol levels in the presence of peroxisome proliferators-activated receptor alpha","volume":"83","author":"Sugiyama","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.yrtph.2010.09.007_b0080","unstructured":"USFDA, 2004a. FDA News Release P04-89. September 8, 2004, FDA Announces Qualified Health Claims for Omega-3 Fatty Acids."},{"key":"10.1016\/j.yrtph.2010.09.007_b0085","unstructured":"USFDA, 2004b. FDA CFSAN Office of Food Additive Safety. Agency Response Letter. GRAS Notice No. GRN 000138, April 20, 2004."},{"key":"10.1016\/j.yrtph.2010.09.007_b0090","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/BF02537488","article-title":"Dietary fish oil and cytochrome P-450 monooxygenase activity in rat liver and kidney","volume":"30","author":"Valdes","year":"1995","journal-title":"Lipids"},{"key":"10.1016\/j.yrtph.2010.09.007_b0095","doi-asserted-by":"crossref","first-page":"25713","DOI":"10.1074\/jbc.273.40.25713","article-title":"The nuclear receptors peroxisome proliferator-activated receptor-\u03b1 and rev-erb\u03b1 mediate the species-specific regulation of apolipoprotein A-1 expression by fibrates","volume":"273","author":"Vu-Dac","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yrtph.2010.09.007_b0100","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomized open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230010001601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230010001601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T21:09:42Z","timestamp":1559682582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230010001601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0273230010001601"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2010.09.007","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}